AKT1 and breast cancer: Depletion of BUB1 in lung adenocarcinoma and breast cancer results in the abrogation of downstream effectors of phosphorylated PI3K/Akt and ERK, thereby leading to the suppression of cell proliferation, migration and invasion.27, 28